PHH CORPORATION (NYSE:PHH) Files An 8-K Completion of Acquisition or Disposition of AssetsItem 2.01. Completion of Acquisition or Disposition of Assets.
On October4, 2018, PHH Corporation (the “Company”) completed its previously announced merger (the “Merger”) with POMS Corp (“Merger Sub”), a wholly owned subsidiary of Ocwen Financial Corporation (“Ocwen”), to that certain Agreement and Plan of Merger, dated as of February27, 2018, by and among the Company, Merger Sub and Ocwen (the “Merger Agreement”). The Company was the surviving corporation in the Merger and, as a result of the Merger, has become a wholly-owned subsidiary of Ocwen. The Company’s 7.375% Senior Notes due 2019 and 6.375% Senior Notes due 2021 (collectively, the “Senior Notes”) remain outstanding after the completion of the Merger.
The descriptions of the Merger Agreement and the transactions contemplated thereby contained in this Current Report on Form8-K does not purport to be complete and are qualified in their entirety by the full and complete text of the Merger Agreement, a copy of which was filed as Exhibit2.1 to the Company’s Current Report on Form8-K filed on February27, 2018 and is incorporated herein by reference.
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Ruleor Standard; Transfer of Listing.
On October4, 2018, the Company notified The New York Stock Exchange (“NYSE”) that the Merger was consummated, and on the same day trading of the Company’s common stock on the NYSE was suspended. In addition, on October4, 2018, the Company requested that the NYSE file a delisting application on Form25 with the Securities and Exchange Commission (the “SEC”) to report the delisting of the Company’s common stock from the NYSE.
The Company intends to file a certification on Form15 with the SEC requesting that the Company’s reporting obligations with respect to its common stock under Sections 13 and 15(d)of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) be suspended. In addition, the Company intends to file a certification on Form15 with the SEC requesting that the Company’s reporting obligations with respect to the Senior Notes under Section15(d)of the Exchange Act be suspended.
Item 3.03. Material Modifications to Rights of Security Holders.
On October4, 2018, as a result of the Merger, each share of the Company’s common stock issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (other than shares owned by Ocwen or Merger Sub (excluding shares held by Ocwen and Merger Sub in mutual funds and the like or otherwise held in a fiduciary or agency capacity, that are beneficially owned by third parties)) was cancelled and automatically converted into the right to receive $11.00 in cash, without interest (the “Merger Consideration”). Holders of the Company’s common stock that was issued and outstanding prior to the Effective Time ceased to have any rights with respect to such securities (other than their right to receive the merger consideration, as applicable), nor do they have any interest in the Company’s future earnings or growth.
At the Effective Time, each outstanding time-based restricted stock unit and performance-based restricted stock unit became vested and was cancelled in exchange for the right of the holder thereof to receive the Merger Consideration in respect of each share of PHH common stock subject to such award (in the case of performance-based restricted stock units, if any shares of PHH common stock were earned under such award based on the actual performance of the Company through immediately prior to the Effective Time). All of the outstanding stock options were cancelled at the Effective Time without any consideration or payment. The information set forth under Items 2.01 and Item 3.01 are incorporated herein by reference.
Item 5.01. Changes in Control of Registrant.
As a result of the Merger, a change in control of the Company occurred, and the Company is now a wholly-owned subsidiary of Ocwen.
The total amount of funds used to complete the Merger and related transactions and pay related fees and expenses was approximately $360 million, which was funded through a combination of the Company’s cash on hand and Ocwen’s cash on hand.
The information set forth under Items 2.01 and 5.02 are incorporated herein by reference.
